Initiating mepolizumab within 3 months of EGPA diagnosis is associated with a higher remission rate, earlier glucocorticoid withdrawal, and less damage accrual.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/earlier-mepolizumab-egpa-linked-higher-remission-rate-and-2026a10005xb?src=rss
Author :
Publish date : 2026-02-25 12:03:00
Copyright for syndicated content belongs to the linked Source.